Allred Capital Management’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$705K Buy
8,805
+2,846
+48% +$235K 0.26% 84
2025
Q4
$508K Sell
5,959
-100
-2% -$8.21K 0.18% 105
2025
Q3
$471K Buy
6,059
+765
+14% +$59.8K 0.16% 115
2025
Q2
$414K Buy
5,294
+162
+3% +$12.1K 0.15% 111
2025
Q1
$372K Sell
5,132
-2,234
-30% -$160K 0.15% 126
2024
Q4
$545K Sell
7,366
-1,729
-19% -$121K 0.21% 99
2024
Q3
$600K Buy
9,095
+11
+0.1% +$799 0.24% 92
2024
Q2
$839K Buy
9,084
+1,103
+14% +$97.7K 0.32% 73
2024
Q1
$763K Buy
7,981
+2,400
+43% +$202K 0.3% 77
2023
Q4
$426K Hold
5,581
0.19% 115
2023
Q3
$387K Buy
5,581
+1,336
+31% +$107K 0.19% 102
2023
Q2
$400K Buy
4,245
+42
+1% +$3.65K 0.2% 98
2023
Q1
$348K Buy
4,203
+1
+0% +$79 0.18% 103
2022
Q4
$314K Hold
4,202
0.17% 109
2022
Q3
$347K Hold
4,202
0.22% 96
2022
Q2
$399K Hold
4,202
0.25% 92
2022
Q1
$494K Sell
4,202
-559
-12% -$62.7K 0.26% 94
2021
Q4
$616K Buy
4,761
+209
+5% +$24.4K 0.3% 84
2021
Q3
$515K Sell
4,552
-206
-4% -$23.5K 0.27% 96
2021
Q2
$492K Buy
4,758
+954
+25% +$89.9K 0.24% 108
2021
Q1
$318K Buy
3,804
+217
+6% +$18.3K 0.14% 146
2020
Q4
$327K Buy
3,587
+464
+15% +$38.5K 0.18% 129
2020
Q3
$249K Buy
+3,123
New +$244K 0.15% 138
2020
Q1
Sell
-756
Closed -$58.8K 315
2019
Q4
$58.8K Buy
+756
New +$59K 0.03% 317

Other funds holding EW

Allred Capital Management's EW Position: Q1 2026 in Review

Allred Capital Management increased its Edwards Lifesciences (EW) stake by 48% in Q1 2026, buying an estimated $235K and bringing the position to 8,805 shares worth $705K. The position accounts for 0.26% of the portfolio, ranked #84.

Allred Capital Management first reported a position in EW in Q4 2019 and has held it in 24 quarters since. The position peaked at $839K in Q2 2024. 1,283 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • Allred Capital Management held 8,805 shares of Edwards Lifesciences worth $705K as of Q1 2026.
  • Allred Capital Management bought 2,846 Edwards Lifesciences shares in Q1 2026, an estimated $235K.
  • Edwards Lifesciences made up 0.26% of Allred Capital Management's portfolio in Q1 2026, its #84 holding.
  • Allred Capital Management first reported a position in Edwards Lifesciences in Q4 2019 and has held it in 24 quarters since.
  • Allred Capital Management's Edwards Lifesciences position peaked at $839K in Q2 2024.
  • 1,283 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on Allred Capital Management's 13F filing for Q1 2026, filed 14 May 2026.